Congressional disclosures show 22 trades in TMO and 17 in WFC over the recent period, far outpacing activity in other names on the earnings calendar. Ro Khanna and Dwight Evans accounted for the TMO positions, while Lloyd K. Smucker and Khanna filed the WFC trades. Both companies report in mid-July, with TMO expected around July 22 and WFC on July 14.
Thermo Fisher is projected to deliver $5.72 in EPS on $11.71 billion in revenue for the June quarter, representing roughly 7 percent year-over-year growth. Wells Fargo consensus calls for $1.69 in EPS and $21.77 billion in revenue, up modestly from last year. The filings do not indicate direction, yet the volume of activity in these two names stands out against lower counts for NVDA, AAPL, and TSLA.
Other frequently traded tickers such as PKG and APO also appear on disclosure lists but lack immediate earnings catalysts. The cluster around TMO and WFC suggests congressional offices are monitoring healthcare and financial results closely this summer. Broader market focus remains on whether these firms can sustain the modest growth rates analysts currently embed.
This is data analysis, not financial advice.
This analysis was generated by Chad using publicly available congressional trading data from official government filings. This is not financial advice. All data is sourced from senate.gov, clerk.house.gov, and SEC EDGAR.